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Abstract The International Society for Clinical
Electrophysiology of Vision (ISCEV) standard for
visual evoked potentials (VEPs) describes a minimum
procedure for clinical VEP testing and encourages
more extensive testing. This ISCEV extended protocol
is an extension to the VEP standard. It describes
procedures for recording multiple VEPs to a range of
sizes of pattern stimuli to establish the VEP spatial
frequency limit (threshold) and for relating this limit to
visual acuity.
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Introduction
The International Society for Clinical Electrophysiol-
ogy of Vision (ISCEV) standard for visual evoked
potentials (VEPs) describes a minimum set of tests but
encourages the use of additional VEP protocols for
clinical testing [1]. This extended protocol describes
the VEP spatial frequency (SF) limit, a specialised
procedure which is well established and broadly
accepted by experts in the field. The protocol was
prepared by the authors in accordance with ISCEV
procedures (www.iscev.org/standards) and was
approved by the ISCEV Board of Directors on May 24,
2020, following a 2-month period of open consultation
with the ISCEV membership. The authors have also
undertaken a systematic review of VEPs used for
acuity estimation to inform this extended protocol, to
provide a contemporary review of the extensive liter-
ature and to examine how associations between VEP
SF limit and visual acuity vary with maturation and
with clinical condition [2].
Scope and applications
VEPs are evoked in the visual cortex and are obtained
by processing electroencephalographic (EEG) signals
from overlying scalp electrodes. An intact and func-
tioning visual pathway between the macula and the
cortex for a specific stimulus can be inferred from the
presence of a normal VEP to that stimulus [1]. Stimuli
can be configured to measure a VEP SF limit as an
estimate of visual acuity: such techniques have been
employed for over 40 years [3, 4]. A VEP SF limit can
be a fully objective measure which requires less
cognitive function or cooperation than behavioural
tests of visual acuity. Thus, VEP SF limits are stand-
alone measures of visual function which complement
behavioural and structural measures. VEP SF limits
and visual acuity are not measurements of the same
entity due to differences in stimuli, retinal area,
fixation duration, level of the visual system assessed
and means of defining a threshold. Despite these
differences, agreement between VEP SF limits and
behavioural measures of acuity can be sufficiently
consistent to make VEPs useful for clinical estimation
of acuity when behavioural testing is not possible or
reliable. An empirical calibration factor or offset (see
Response evaluation, part (c)) is usually required to
estimate behavioural visual acuity from VEP SF
limits: such factors depend on the specific VEP SF
limit method, the acuity test, the subject’s age, the type
of visual dysfunction and, to a lesser extent, the
subject’s acuity. This empirically determined calibra-
tion factor is required to infer visual acuity from a VEP
SF limit: for example, it is incorrect to assume that a
VEP SF limit of 30 cycles per degree (cpd) is
equivalent to a visual acuity of 0.0 logMAR, i.e. 1.0
(decimal), 6/6 or 20/20 (Snellen) as this relationship
often fails to hold for VEP SF limits.
We have adopted a terminology convention for
thresholds, acuity and related measures which uses
‘‘good’’, ‘‘better’’, ‘‘poor’’ or ‘‘poorer’’ in preference to
‘‘high’’, higher’’, ‘‘low’’ or ‘‘lower’’ since some units
such as the logMAR scale are such that lower
numerical values denote better performance. Pattern
element sizes are described as ‘‘coarse’’ or ‘‘fine’’ in
preference to ‘‘high’’ or ‘‘low’’ since SF units such as
cpd, and element size units such as minutes of arc (0),
have an inverse relation and therefore opposite
meanings of ‘‘low’’ and ‘‘high’’. We have used
‘‘VEP SF limit’’ to describe the performance limit as
measured by VEPs in preference to alternatives such
as VEP SF threshold, VEP acuity, VEP acuity estimate
or sweep VEP acuity.
Patient populations
Visual acuity is typically measured using subjective
tests such as letter charts which require the patient to
have adequate cognitive and motor function and to
comply with the test process. VEP SF limits are
indicated in patients who cannot or will not cooperate
or satisfactorily complete behavioural acuity tests or
whose cooperation is suspect. VEP SF limits are useful
for estimating acuity in infants and children, partic-
ularly those with motor or learning impairments which
prevent reliable measurement of behavioural acuity.
Typical VEP SF limits improve rapidly over the first
year of life and then more slowly, reaching adult levels
between 2 and 10 years of age. In the youngest
typically developing infants, VEP SF limits are much
better (i.e. occur at finer SF) than behavioural acuity
measured with acuity card tests based on fixation
preference, but the reverse is found from around
3–5 years onwards. For this reason, inferring a
behavioural visual acuity from an individual infant
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or child’s VEP SF limit cannot use empirical calibra-
tions established for adults.
VEP SF limits can be a good proxy for behavioural
acuity in patients with media opacities, refractive
errors and primarily retinal dysfunction. In patients
whose primary site of dysfunction is the macula, the
optic nerve or any cerebral structure, VEP SF limits
may have poorer accuracy and precision when com-
pared to behavioural measures: this includes ambly-
opic patients in whom VEP SF limits are relatively
insensitive to reduced optotype acuity. VEP SF limits
are particularly helpful in patients with non-organic
vision loss providing sufficiently fine SFs are used.
A VEP SF limit should be ordered and interpreted only
as part of a fuller assessment and cannot be interpreted
without full clinical assessment and history.
Technical issues
A broad overview of commonly used techniques is
shown in Fig. 1.
a. VEP stimuli VEP amplitude is tuned to temporal
frequency and largest for stimuli which change in
the range of 5–12 Hz. For reversing stimuli, there
are two reversals in each cycle, so 5–12 Hz is
equivalent to 10–24 reversals per s (rps). Within
this approximate range, VEP SF limits are
relatively constant. VEP SF limits improve with
increasing mean luminance, reaching stability
across the range of 25–100 cd/m2. Generally,
higher contrast improves signal-to-noise ratio
(SNR) and hence VEP SF limits, but contrast
levels[ 40% (Michelson) enhance a well-recog-
nised amplitude notch (reduced amplitude VEPs
at intermediate SFs) in the amplitude versus SF
tuning curve, risking underestimation of VEP SF
limits. Lower contrast also reduces the risk of
luminance artefacts and may be more comfort-
able to view. VEP SF limits remain relatively
stable over a large range of field sizes (2–12);
larger field sizes may compensate a little for poor
fixation. Checkerboards, sinusoidal gratings and
square wave gratings (bars) are widely used.
While sinusoidal gratings are spatially simpler,
containing a single SF, the sharp edges of square
wave gratings or checkerboards contain multiple
finer SFs and may provide a better accommodative
stimulus. Grating orientation (horizontal vs verti-
cal) does not affect VEP SF limits, but oblique
orientations give poorer VEP SF limits, i.e. at
lower SF, than cardinal orientations. A checker-
board’s fundamental SF (SFf) is oriented obli-
quely (see Eq. 1) at 45 and at 135 degrees, so VEP
SF limits to checkerboard stimuli may be poorer
than those to grating stimuli. Reversing stimuli
produce a more marked notch in the SF tuning
curve than onset/offset stimuli. Brief onsets (e.g.
40 ms) cause the on- and off-responses to overlap,
producing a larger VEP than longer onsets (e.g.
300 ms [1]).
b. Stimulus sequencing True sweep VEPs, i.e. con-
tinuously changing SFs, have been superseded by
‘‘stepwise sweep’’ methods, where SF is changed
in discrete steps. Extrapolation techniques require
adequately dense and extensive sampling of the
VEP amplitude versus SF function, especially
with reversing stimuli which may produce a
notched function, i.e. reduced amplitude at inter-
mediate SFs. In healthy adults and older children,
patterns of up to 40 cpd may be required in order
to approach or bracket their VEP SF limit and
avoid underestimation errors. Linear sampling of
SF produces desirably fine sampling towards the
VEP SF limit of normal adults, but linear changes
in SF cannot always be achieved for the finest
patterns available on a display, e.g. 1 9 1 to
2 9 2 to 3 9 3 pixels. Exponential sampling
gives equal weight to each octave of SF, as for a
psychophysical tuning function, but spatial reso-
lution is reduced towards the acuity limit. For
sequential SF presentation, the direction of change
(coarse-to-fine or fine-to-coarse) has little or no
effect on VEP SF limits, although patients may be
more attentive to coarse-to-fine stepwise sweeps.
c. Acquisition and analysis Active electrodes close
to Oz are optimally positioned to define VEP SF
limits well. Closely positioned reference elec-
trodes, especially in a Laplacian montage,
enhance SNR towards threshold by cancelling
remote noise. VEPs acquired at rates of 5–12 Hz
(onset/offset) or 10–24 rps are usually analysed in
the frequency domain using a discrete Fourier
transform (DFT), sometimes after time-domain
averaging. Epochs containing artefacts can be
rejected in real time or post hoc and excluded from
any time-domain average or other analysis.
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Typically, only the first harmonic (response at the
stimulus frequency for onset/offset stimuli) or the
second harmonic (response at the reversal rate for
reversing stimuli) is considered since magnitude is
usually lower for higher harmonics. Incorporating
higher harmonics, for example by summing all
harmonics which are significantly greater than
noise, may be useful for improving overall SNR.
The presence or absence of a VEP at the stimulus
frequency is determined objectively, for example
SNR C 3. Noise can be estimated as the
magnitude of an adjacent frequency bin in the
DFT spectrum, or as the mean of the two adjacent
bins, or from no-stimulus recordings. DFT phase
data may be incorporated into decision-making by
requiring physiologically plausible phase lead or
lag with decreasing or increasing SF, respectively.
Both magnitude and phase can be employed in
bivariate techniques such as the circular T2
statistic or magnitude-squared coherence statistic.
d. Defining the VEP SF limit Extrapolation tech-
nique: For each SF used as a stimulus, the VEP
Fig. 1 Illustrative overview of processes used to measure VEP
SF limits. Panel a/b illustrates options for stimuli (gratings or
checkerboards) and sequencing. Panel c illustrates a possible
four-channel acquisition montage with one channel emulating
the ISCEV VEP standard, Oz–Fz [1], two using closely
positioned reference electrodes over the right occiput (RO)
and left occiput (LO) (Oz–RO and Oz–LO) and the fourth using
a Laplacian montage, Oz–((RO ? LO)/2). Panel d illustrates an
example of frequency domain analysis, with steady-state VEPs
evident as the numbered spikes at the stimulus frequency and
higher harmonics. Panel e illustrates one signal detection
technique, the circular T2 (red circle encloses the origin and
represents a non-significant steady-state VEP; green circle
excludes the origin and illustrates a significant steady-state
VEP)—other statistical techniques are also listed. Panel f
illustrates one method for defining VEP SF limit, namely linear
regression and extrapolation of the significant VEP magnitudes
in the descending limb at the finest spatial frequencies:
alternative methods are listed. SF, spatial frequency; SNR,
signal-to-noise ratio; CI, confidence interval; cpd, cycles per
degree
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magnitude (lV) is plotted versus SF (cpd).
Typically, this SF tuning function drops towards
zero at finer SFs (see example plot, Fig. 1, panel
f). Selecting only those points on this final
descending portion, and performing linear regres-
sion through them, allows extrapolation of the
straight line to 0 lV or to a noise ‘‘floor’’: the point
of intersection defines the VEP SF limit. Regres-
sion is typically performed on only significant
VEP magnitudes. The SF axis may be linearly or
logarithmically scaled. If extrapolation is per-
formed to 0 lV rather than to a noise ‘‘floor’’, VEP
magnitudes may be adjusted for noise by sub-
tracting a noise estimate.
Finest SF technique: A VEP SF limit can also be
defined as the finest SF evoking a significant VEP,
with due regard to suitable thresholding, i.e.
significant VEPs to slightly coarser SFs and
absent VEPs to slightly finer SFs. This technique
may produce VEP SF limits which are slightly
poorer than those found by the extrapolation
technique. The finest SF technique may be used as
an alternative, integrated strategy when the
extrapolation technique fails to define a VEP SF
limit.
e. Transient VEPs and transient VEPs for SF limit
measurement ISCEV standard transient VEPs are
recorded to checkwidths of 600 and 150 (0.71 and
2.8 cpd). It is not advisable to attribute an acuity
based on their presence, absence or normality. For
example, an extant VEP (transient or steady-state)
to a 150 (2.8 cpd) checkwidth pattern would be in
keeping with ‘‘good visual acuity’’ for a baby, but
as a limit, this would be much poorer than typical
for any patient aged over 1 year. In some cases,
the presence of a transient VEP may suggest
grossly better visual acuity than reported subjec-
tively, for example in cases of severe non-organic
visual loss, but this observation lacks precision
regarding a SF limit.
Transient VEP SF limits can be used to estimate
acuity, but it takes much longer than steady-state
VEP methods to evoke reproducible responses to
multiple SFs, and limits are therefore more prone to
be affected by patient fatigue and neural adaptation.
Furthermore, objective detection techniques for
transient VEPs have not been widely adopted and
subjective recognisability of transient VEP
waveforms risks inter-operator differences in lim-
its; transient VEPs are therefore not included this
extended protocol.
Calibration
Calibration of stimulation and recording systems
should be verified and re-calibrated if indicated at
intervals as specified in the current ISCEV VEP
standard and calibration guideline [1, 5]. It is partic-
ularly important that users ensure the absence of any
luminance artefact such as transient artefacts created
by non-CRT screens or artefacts introduced in onset/
offset stimuli due to luminance or spectral differences
between the grey background and the pattern. All
pattern element sizes, for example checkwidths,
should be directly measured to verify the visual angle
subtended. Patterns should be expressed in cpd using
appropriate conversion formulae (Table 1 in [2]). In
particular, the obliquely oriented SFf (cpd) of a
checkerboard is expressed as
SFf ¼ 60ffiffiffi
2
p
wc
ð1Þ
where wc is the visual angle subtended by one
checkwidth in minutes of arc.
An empirical calibration factor is required to infer a
behavioural acuity from a VEP SF limit: see Response
evaluation part (c) below.
Protocol specifications
Patient preparation follows that of the current VEP
standard [1], except for the reference electrode place-
ment (see (e) Electrode montage, below). Measurement
of the VEP SF limit may precede or follow ISCEV
standard minimum protocols. Binocular stimulation is
used when the aim is to gain insight into practical
functioning levels. Monocular testing is used when
interocular differences are suspected. Patients should be
physically well supported which may mean using a
carer’s lap with heads supported securely for infants or
small children or the patient’s own mobility chair.
a. Fixation and ambient lighting Fixation should be
closely monitored during recording and acquisi-
tion suspended during poor fixation. The quality of
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the EEG signal should be monitored, and auto-
mated artefact rejection can be used. Ambient
lighting should be chosen to maximise the
patient’s attention and fixation on the stimulus
screen.
b. Refraction and mydriasis Patients should wear any
required refraction, and pupils should not be
pharmaceutically dilated. Cycloplegia and opti-
mal refractive correction for the fixation dis-
tance may be useful for some patients, for
example in some cases of suspected malingering
or factitious disorders.
c. Spatial and temporal stimulus parameters This
protocol requires vertical or horizontal sinusoidal
or square wave gratings, or checkerboards, pre-
sented in either onset/offset or reversal mode with
a temporal frequency of 5–12 Hz (onset/offsets)
or 10–24 reversal per s (reversals), to evoke
steady-state VEPs. Onsets should be brief, for
example 40 ms, and should not exceed 60 ms.
Mean luminance should be approximately 50 cd/
m2 (acceptable range 25–100 cd/m2). Michelson
contrast around 40% is specified to minimise any
notch in the SF tuning curve and commensurate
risk of VEP SF limit underestimation: however,
higher contrasts may be used if needed for better
SNR, for example in pathologies affecting con-
trast sensitivity. A field size[ 15, as for the VEP
standard, is suitable, but may need to be smaller to
accommodate increased viewing distances
required for fine SFs: field size should not be less
than 3 in diameter. Field sizes larger than 15
may help compensate for poor fixation or to enable
display of the coarsest SFs.
d. Sequence and range of stimuli The range of SFs
should be tailored to the needs of each patient as
far as possible, with the finest SFs presented being
beyond their VEP SF limit. Either linear or
exponential (i.e. linear on a logarithmically scaled
axis) sampling of SF is suitable. Successful
strategies tend to use 8–20 SFs, although fewer
are possible if there are sufficient points above and
below the VEP SF limit. Coarse-to-fine or fine-to-
coarse SF sequencing is acceptable, as is random,
pseudo-random or staircasing sequences. Patients
may be more attentive to coarse-to-fine stepwise
sweeps.
e. Electrode montage A single channel recording
with the active electrode at Oz, as for ISCEV
standard VEPs, is adequate; the reference elec-
trode is closely positioned, for example at O1, O2
or Pz. Two or more channels, for example Oz
referenced to O1 and Oz referenced to O2, may be
used, and data from whichever channel has the
highest SNR can be selected. Channels could
use montages with more distant reference elec-
trodes, e.g. Cz or Fz, as for ISCEV standard VEPs.
Using a Laplacian montage to enhance VEP
detection is also acceptable and can be imple-
mented using two close reference electrodes, e.g.
O1 and O2, and a ‘‘virtual’’ channel derived as
Oz - ((O1 ? O2)/2). A separate electrode, at a
site such as the forehead, vertex (Cz), mastoid or
earlobe, should be connected to the ground.
Response evaluation
a. Data analysis Magnitude and phase of the EEG
signal at the stimulus frequency for onset/offset or
at the reversal rate for pattern-reversal stimuli
should be determined with a suitable technique,
for example the DFT. Artefact rejection should be
used, e.g. exclusion of epochs containing artefact
from time-domain averaged data. Significance of
the signal should be established objectively based
on magnitude and/or phase statistics.
b. VEP SF limit The VEP SF limit is defined as the
extrapolated limit or the finest SF evoking a
significant VEP. Both magnitude and phase plots
with axes labelled with relevant units (e.g. lV and
degrees vs stimulus SFf (cpd)) should be inspected
for physiologically plausible findings, e.g. reason-
able magnitudes and phase lag increasing with SF.
Plots should indicate which SFs evoked significant
or non-significant VEPs and which were used for
any regression. To meet this extended protocol, all
users should pre-specify rules for determining the
limit. These rules may be automatically applied or
may have a manual element, such as selecting
points for regression or excluding artefacts that
meet specific criteria. Any manual rules should be
pre-specified and applied identically by all oper-
ators to avoid different operators finding different
limits from the same data. VEP SF limits at this
stage should be described as the VEP stimulus at
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the SF limit (cpd) and not converted into an
estimate of behavioural acuity.
c. Option of inferring a behavioural acuity If VEP
SF limits are used to infer a behavioural acuity, an
empirical calibration factor is required. This
should be derived empirically from an adequately
sized group of subjects from whom both VEP SF
limits and behavioural acuities have been
obtained. Some measure of the spread of values,
for example limits of agreement, as well as a point
estimate of the average offset should be given.
Empirical calibration factors derived from adult
subjects are not valid for infants or children
younger than 3–5 years old. Where a calibration
factor from elsewhere is used, e.g. from indepen-
dent studies or as part of a manufacturer’s
protocol, its provenance should be available in
sufficient detail to allow new users to judge its
transferability to their patient population.
Reporting
Full details of all stimulus, acquisition and analysis
parameters, pertinent recording details such as quality
of fixation and plots of VEP magnitude and phase vs
SF should be included or available. The plots should
indicate all SFs which were employed and those which
evoked significant VEPs. If extrapolation is used, the
regression line and the SFs regressed should also be
indicated. If extrapolation is not used, the criterion for
the VEP SF limit should be stated, i.e. the finest SF
evoking a significant VEP. Limits should be given in
cpd. Reports should state age-appropriate reference
intervals in cpd, including their provenance, and a
statement of normality or otherwise for the patient
tested.
There is no requirement for the further step of
relating the VEP SF limit to behavioural acuity
measures. If this is undertaken, reports should explic-
itly state what empirical calibration factor has been
applied with access to a reference for its provenance
which provides details such as ages of subjects,
behavioural acuity tests used and a measure of
variability, for example limits of agreement. Reports
should advise caution with interpreting results for
patients whose known or suspected type of visual
dysfunction potentially makes their VEP SF limit an
unreliable estimate of behavioural acuity.
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Appendix: Justification of the protocol details
The committee was formed of individuals from
diverse centres with experience of development and/
or use of clinical VEP SF limits. To minimise bias, a
systematic review was undertaken. In brief, four
databases were independently searched using appro-
priate MeSH terms or equivalent keywords for studies
(articles, conference proceedings or dissertations)
describing VEPs used to estimate visual acuity in
humans. Titles and abstracts and, where necessary, full
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texts were screened to identify potentially eligible
studies for inclusion. Data were extracted from
included studies using a standardised template. The
protocol was registered with the international prospec-
tive register of systematic reviews (PROSPERO),
registration number CRD42018085666, and method-
ology is reported according to the Preferred Reporting
Items for Systematic Reviews and Meta-Analyses
(PRISMA) statement [6]. This extended protocol is an
informed distillation of the findings of the systematic
review [2].
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